questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Furanes
Furanes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Exposition professionnelle
Toxicologie
Analyse de sang
Analyse d'urine
Marqueurs biologiques
Furanes
Évaluation des risques
Exposition professionnelle
Symptômes
5
Effets à long terme
Troubles neurologiques
Système respiratoire
Irritation
Système immunitaire
Exposition prolongée
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Ventilation
Industrie alimentaire
Contrôle de la température
Réglementations
Exposition professionnelle
Formation
Risques professionnels
Traitements
5
Antidotes
Traitement symptomatique
Irritation cutanée
Traitement topique
Soins d'urgence
Évaluation médicale
Complications
5
Complications
Troubles respiratoires
Cancers
Potentiel cancérigène
Reproduction
Développement fœtal
Système nerveux
Neuropathies
Facteurs de risque
5
Travailleurs
Industrie chimique
Pollution de l'air
Industries
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Furanes : Questions médicales les plus fréquentes",
"headline": "Furanes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Furanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Furanes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétéromonocycliques",
"url": "https://questionsmedicales.fr/mesh/D006573",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétéromonocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "4-Butyrolactone",
"alternateName": "4-Butyrolactone",
"url": "https://questionsmedicales.fr/mesh/D015107",
"about": {
"@type": "MedicalCondition",
"name": "4-Butyrolactone",
"code": {
"@type": "MedicalCode",
"code": "D015107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides citraconiques",
"alternateName": "Citraconic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D002949",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides citraconiques",
"code": {
"@type": "MedicalCode",
"code": "D002949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Darunavir",
"alternateName": "Darunavir",
"url": "https://questionsmedicales.fr/mesh/D000069454",
"about": {
"@type": "MedicalCondition",
"name": "Darunavir",
"code": {
"@type": "MedicalCode",
"code": "D000069454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.303"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furfural",
"alternateName": "Furaldehyde",
"url": "https://questionsmedicales.fr/mesh/D005662",
"about": {
"@type": "MedicalCondition",
"name": "Furfural",
"code": {
"@type": "MedicalCode",
"code": "D005662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lasalocide",
"alternateName": "Lasalocid",
"url": "https://questionsmedicales.fr/mesh/D007832",
"about": {
"@type": "MedicalCondition",
"name": "Lasalocide",
"code": {
"@type": "MedicalCode",
"code": "D007832",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anhydrides maléiques",
"alternateName": "Maleic Anhydrides",
"url": "https://questionsmedicales.fr/mesh/D008299",
"about": {
"@type": "MedicalCondition",
"name": "Anhydrides maléiques",
"code": {
"@type": "MedicalCode",
"code": "D008299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Monensin",
"alternateName": "Monensin",
"url": "https://questionsmedicales.fr/mesh/D008985",
"about": {
"@type": "MedicalCondition",
"name": "Monensin",
"code": {
"@type": "MedicalCode",
"code": "D008985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Naftidrofuryl",
"alternateName": "Nafronyl",
"url": "https://questionsmedicales.fr/mesh/D009257",
"about": {
"@type": "MedicalCondition",
"name": "Naftidrofuryl",
"code": {
"@type": "MedicalCode",
"code": "D009257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofuranes",
"alternateName": "Nitrofurans",
"url": "https://questionsmedicales.fr/mesh/D009581",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofuranes",
"code": {
"@type": "MedicalCode",
"code": "D009581",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"alternateName": "5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",
"url": "https://questionsmedicales.fr/mesh/D013184",
"about": {
"@type": "MedicalCondition",
"name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine",
"code": {
"@type": "MedicalCode",
"code": "D013184",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"alternateName": "FANFT",
"url": "https://questionsmedicales.fr/mesh/D005200",
"about": {
"@type": "MedicalCondition",
"name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide",
"code": {
"@type": "MedicalCode",
"code": "D005200",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furagine",
"alternateName": "Furagin",
"url": "https://questionsmedicales.fr/mesh/D005661",
"about": {
"@type": "MedicalCondition",
"name": "Furagine",
"code": {
"@type": "MedicalCode",
"code": "D005661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.308"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Furazolidone",
"alternateName": "Furazolidone",
"url": "https://questionsmedicales.fr/mesh/D005664",
"about": {
"@type": "MedicalCondition",
"name": "Furazolidone",
"code": {
"@type": "MedicalCode",
"code": "D005664",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.313"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"alternateName": "Furylfuramide",
"url": "https://questionsmedicales.fr/mesh/D005668",
"about": {
"@type": "MedicalCondition",
"name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide",
"code": {
"@type": "MedicalCode",
"code": "D005668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nifuratel",
"alternateName": "Nifuratel",
"url": "https://questionsmedicales.fr/mesh/D009545",
"about": {
"@type": "MedicalCondition",
"name": "Nifuratel",
"code": {
"@type": "MedicalCode",
"code": "D009545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofurantoïne",
"alternateName": "Nitrofurantoin",
"url": "https://questionsmedicales.fr/mesh/D009582",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofurantoïne",
"code": {
"@type": "MedicalCode",
"code": "D009582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.566"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrofural",
"alternateName": "Nitrofurazone",
"url": "https://questionsmedicales.fr/mesh/D009583",
"about": {
"@type": "MedicalCondition",
"name": "Nitrofural",
"code": {
"@type": "MedicalCode",
"code": "D009583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.691"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrovin",
"alternateName": "Nitrovin",
"url": "https://questionsmedicales.fr/mesh/D009610",
"about": {
"@type": "MedicalCondition",
"name": "Nitrovin",
"code": {
"@type": "MedicalCode",
"code": "D009610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.649.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ranitidine",
"alternateName": "Ranitidine",
"url": "https://questionsmedicales.fr/mesh/D011899",
"about": {
"@type": "MedicalCondition",
"name": "Ranitidine",
"code": {
"@type": "MedicalCode",
"code": "D011899",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.312.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Furanes",
"alternateName": "Furans",
"code": {
"@type": "MedicalCode",
"code": "D005663",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anja Rahn",
"url": "https://questionsmedicales.fr/author/Anja%20Rahn",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Chahan Yeretzian",
"url": "https://questionsmedicales.fr/author/Chahan%20Yeretzian",
"affiliation": {
"@type": "Organization",
"name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch."
}
},
{
"@type": "Person",
"name": "Yinbo Wan",
"url": "https://questionsmedicales.fr/author/Yinbo%20Wan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Haiyun Peng",
"url": "https://questionsmedicales.fr/author/Haiyun%20Peng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
},
{
"@type": "Person",
"name": "Guisheng Deng",
"url": "https://questionsmedicales.fr/author/Guisheng%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke.",
"datePublished": "2024-08-30",
"url": "https://questionsmedicales.fr/article/39214654",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2024-085945"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction among homeless smokers in a randomized controlled trial targeting cessation.",
"datePublished": "2022-05-21",
"url": "https://questionsmedicales.fr/article/35689905",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addbeh.2022.107373"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37458789",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00213-023-06401-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking reduction using an electronic nicotine delivery system (ENDS) with nicotine delivery similar to combustible cigarettes.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-024-01064-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nicotine-Free E-Cigarettes Might Promote Tobacco Smoking Reduction Better Than Nicotine Delivery Devices: Results of a Double-Blind Randomized Controlled Trial at 1 Year.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36421329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol29110676"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Furanes",
"item": "https://questionsmedicales.fr/mesh/D005663"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Furanes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Furanes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Furanes",
"description": "Comment diagnostiquer une exposition aux furanes ?\nQuels tests sont utilisés pour détecter les furanes ?\nQuels symptômes indiquent une intoxication aux furanes ?\nY a-t-il des marqueurs biologiques pour les furanes ?\nComment évaluer le risque d'exposition aux furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Furanes",
"description": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?\nLes furanes provoquent-ils des effets à long terme ?\nComment les furanes affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les travailleurs exposés ?\nLes furanes affectent-ils le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Furanes",
"description": "Comment prévenir l'exposition aux furanes ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes furanes peuvent-ils être évités dans l'industrie alimentaire ?\nQuelles sont les réglementations concernant les furanes ?\nLes travailleurs doivent-ils être formés sur les furanes ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Furanes",
"description": "Quel est le traitement de l'intoxication aux furanes ?\nDes antidotes existent-ils pour les furanes ?\nComment traiter les irritations cutanées causées par les furanes ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nQuel suivi médical est recommandé après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Furanes",
"description": "Quelles complications peuvent survenir après exposition aux furanes ?\nLes furanes peuvent-ils causer des cancers ?\nComment les furanes affectent-ils la reproduction ?\nLes furanes peuvent-ils affecter le foie ?\nY a-t-il des effets sur le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Furanes",
"description": "Qui est le plus à risque d'exposition aux furanes ?\nLes fumeurs sont-ils plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables aux furanes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Smoking+Reduction#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux furanes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter des métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les furanes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour identifier les métabolites des furanes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux furanes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les furanes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le 2-furylméthylcétone peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux furanes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des sources potentielles d'exposition est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées, des irritations cutanées et respiratoires."
}
},
{
"@type": "Question",
"name": "Les furanes provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des effets chroniques comme des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations des voies respiratoires, des toux et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les travailleurs exposés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs peuvent présenter des symptômes comme des vertiges, des maux de tête et des troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Les furanes affectent-ils le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut altérer la réponse immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux furanes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité au travail."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être mises en place ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de ventilation adéquats et des formations sur les risques chimiques sont essentiels."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils être évités dans l'industrie alimentaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en contrôlant les températures de cuisson et en évitant les méthodes de cuisson à haute température."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations concernant les furanes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réglementations strictes existent pour limiter l'exposition professionnelle et environnementale."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les furanes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est cruciale pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'intoxication aux furanes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la source d'exposition et à gérer les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les furanes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les furanes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de rincer la zone affectée et d'appliquer des crèmes apaisantes ou corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de symptômes graves, une évaluation médicale urgente est nécessaire."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller les effets à long terme et la santé générale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux furanes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment les furanes affectent-ils la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition peut entraîner des effets néfastes sur la reproduction et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Les furanes peuvent-ils affecter le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition peut entraîner des lésions hépatiques et des troubles fonctionnels du foie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur le système nerveux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut causer des troubles neurologiques, y compris des neuropathies."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux furanes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus exposés aux furanes."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus à risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter l'exposition aux furanes présents dans la fumée de cigarette."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux furanes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des furanes en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution de l'air et la proximité d'industries émettrices de furanes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents de maladies respiratoires ou hépatiques sont plus à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China.
Key Laboratory of the Assembly and Application of Organic Functional Molecules of Hunan Province, Hunan Normal University, Changsha 410081, China.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Manchester Manchester M13 9PL UK.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
UR Molecular Systems, Department of Chemistry, University of Liège 4000 Liège Belgium fremacle@uliege.be.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
School of Chemical and Materials Sciences, Indian Institute of Technology Goa, GEC Campus Farmagudi Goa-403401 India rishikesh.narayan@iitgoa.ac.in.
School of Interdisciplinary Life Sciences, Indian Institute of Technology Goa GEC Campus, Farmagudi Goa-403401 India.
Publications dans "Furanes" :
2 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, Dongguk University-Seoul, 32, Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 400-820 Republic of Korea.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weißenburger Straße 3, 76187 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Analytical Chemistry (170a), Institute of Food Chemistry, University of Hohenheim, 70599 Stuttgart, Germany. Electronic address: claudia.oellig@uni-hohenheim.de.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
Institute of Physical Chemistry, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76131 Karlsruhe, Germany.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
1 publication dans cette catégorie
Affiliations :
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
National Centre for Atmospheric Science, School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom.
Publications dans "Furanes" :
To explore the acceptability and perceived motivations and barriers of using nicotine replacement therapy (NRT) to reduce the number of daily cigarettes smoked in pregnancy, rather than for stopping c...
Telephone, semi-structured interviews, audio-recorded and transcribed verbatim. Transcripts were analysed using an inductive thematic analysis....
Eighteen pregnant women in the UK, who were smoking or had recently stopped smoking, were recruited....
Half of interviewees reported having used NRT to reduce smoking during their current pregnancy, and there was overwhelming support for the UK National Health Service to recognise this as a potentially...
Using NRT to help women, who are unable to stop smoking, to reduce their smoking may be acceptable to pregnant women. This study found women were already using NRT alongside ad hoc strategies to reduc...
Homeless populations have high rates of smoking and unique barriers to quitting. General cessation strategies have been unsuccessful in this population. Smoking reduction may be a good intermediate go...
Data are from an RCT comparing motivational interviewing counseling plus nicotine replacement therapy (NRT) to brief advice to quit (standard care) plus NRT among homeless smokers. Using bivariate ana...
Of 324 participants who completed 26-week follow-up, 18.8% and 63.9% self-reported quitting and reducing, respectively. Compared to those who did not reduce smoking, participants reporting reducing in...
Over half of participants reduced smoking by at least 50%, indicating reduction is feasible among homeless smokers. Further research is required to understand the impact of reduction on future cessati...
Electronic nicotine delivery systems (ENDS) are used by smokers seeking to reduce combustible cigarette (CC) use, but the role of nicotine replacement vs. behavioral and sensory factors is still poorl...
To assess the effects on smoking behavior of using nicotine vs. placebo ENDS in smokers using nicotine vs. placebo patches....
Ninety-four daily smokers were enrolled in a study that randomly assigned them to receive ENDS with nicotine vs. without nicotine and skin patches with vs. without nicotine. Smoking reduction and cess...
The use of nicotine in ENDS led to significant reductions in smoking (ENDS nicotine vs. placebo difference in CO change = -9.2 ppm; 90% CI (-1.5 ppm, -16.9 ppm)) and was highly correlated with reducti...
The presence of nicotine in ENDS was associated with a large reduction in smoking. Additional studies will be needed to determine whether there may be additive effects of nicotine ENDS and nicotine pa...
Electronic nicotine delivery systems (ENDS) offer a promising approach to tobacco harm reduction, but many people use both ENDS and combustible cigarettes ("dual use"), which undermines potential risk...
Twenty-five cigarette smoking adults, not seeking smoking cessation treatment, but open to using ENDS as a cigarette substitute, were provided with a 12-week supply of BIDI...
Over 12 weeks, ENDS use increased to an average of 15.8 occasions per day (SD = 20.2) and self-reported cigarette consumption decreased by 82% from 16.7 cigarettes/day (SD = 6.0) at baseline to 3.0 ci...
In this study, the ENDS effectively replicated the subjective rewarding effects of participants' usual brands of cigarettes and led to a substantial reduction in reported cigarettes/day. Exhaled CO sh...
ClinicalTrials.gov identifier NCT05855343....
The purpose of the present study was to determine whether the use of e-cigarettes to aid in quitting contributed to the increase in the pulmonary health of chronic smokers. The efficacy of e-cigarette...
Smoking-related weight control expectancies are a motivational factor for maintaining cigarette use, particularly among women. Yet, less research has investigated the physiological and behavioral dail...
This study looked into the effectiveness of a 6 month health coaching intervention in smoking cessation and smoking reduction for patients with type 2 diabetes....
The study was carried out via a two-armed, double-blind, randomized-controlled trial with 68 participants at a medical center in Taiwan. The intervention group received health coaching for 6 months, w...
In this study, the intervention group had significantly more participants who reduced their level of cigarette smoking by at least 50% than the control group (...
Health coaching can be an effective approach to assisting patients with type 2 diabetes participating in a pharmacotherapy plan to reduce smoking and may help those who participate in pharmacotherapy ...
There has been long-standing interest in a reduced-nicotine product standard for combusted tobacco, which is within the regulatory purview of the Food and Drug Administration (FDA). In weighing whethe...
The association between smoking cessation and decreased mortality existed among former smokers has been well documented. However, evidence is limited for smokers with long-term exposure. This study ai...
Data from Beijing Healthy Aging Cohort Study (BHACS), conducted among communities aged over 55 years old at recruitment, were collected via questionnaire between July 2009 and September 2015 and follo...
A total of 11 235 participants (43.9% male) were included, with a mean age of 70.35 (SD 7.71) years. Former smokers comprised 31.7% of the cohort, with a median smoking duration of 43 (IQR: 34-50) yea...
In this study, current smoking was associated with nearly triple the mortality risk compared to never smoking. Smoking cessation, even after a long-term smoking history, was associated with significan...
Surgical smoke is an occupational health problem and is increasingly recognized as a potential source of virus transmission. Dedicated smoke evacuators are used to protect against surgical smoke expos...
A randomized, double-blind clinical trial was conducted in patients undergoing laparotomy from June 11, 2021, to March 30, 2022, to compare the effectiveness of smoke evacuators with a control (regist...
A total of 42 patients were randomized and assessed (smoke evacuator group, n = 22 vs. control group, n = 20). The acetaldehyde level was significantly lower in smoke evacuator group than in control g...
Dedicated smoke evacuators reduced the level of acetaldehyde and formaldehyde, and the number of particles in surgical smoke, minimizing the potential exposure to VOCs and particle matters during surg...